clinical trial · NCT01468584
Efficacy and Safety of MP-424, Peginterferon Alfa-2b and Ribavirin in Non-responder Genotype 2 Hepatitis C Infected Patients
Chronic Hepatitis CMP-424 (generic name:Telaprevir)RibavirinPeginterferon alfa-2b
brief summary
This study will evaluate the efficacy and safety of MP-424 with Peginterferon Alfa-2b and Ribavirin (RBV) in patients with genotype 2 hepatitis C, who did not respond to previous treatment.
started
Nov 1, 2011
primary completion
Sep 1, 2013
completion
Sep 1, 2013
last updated
Jan 6, 2026
official title
A Phase 3 Study of MP-424 in Combination With Peginterferon Alfa-2b and Ribavirin, in Subjects With Genotype 2 Hepatitis C, Who Did Not Respond to Previous Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol